Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US

Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US

Date
March 1, 2017
Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more